About us — What we do
Preclinical in vivo research expertise
Supporting preclinical drug development through advanced in vivo models, longitudinal imaging and integrated biological read-outs.
Integrated preclinical in vivo research
At IVRS, we design and perform preclinical in vivo studies to evaluate disease progression, therapeutic response, biodistribution and potential toxicity. Our disease-specific models are combined with longitudinal 2D and 3D imaging to monitor biological changes in living animals throughout the study.
By integrating advanced imaging with complementary biological read-outs, we generate quantitative data to support drug validation and informed preclinical development decisions.
Our in vivo imaging capabilities enable longitudinal tracking of cells,
antibodies, small molecules and nanoparticles to investigate:
- Tumor progression and metastatic spread
- PK/PD and biodistribution
- Chronic inflammation and disease-associated changes
- Target validation and therapeutic response
- Early drug-induced toxicity and safety signals
- Implanted sensors for longitudinal biological monitoring
Available read-outs
Our studies integrate imaging and complementary biological read-outs. Core imaging capabilities are performed in-house at IVRS, while additional analyses are delivered through our established scientific partner network.
Performed end to end in our own facilities at Medicon Village in Lund.
Longitudinal in vivo imaging
2D & 3D bioluminescence and NIR imaging
Delivered through our established partner network, coordinated by IVRS.
Confocal microscopy
Biomarker analysis
In vitro functional assays
Flow cytometry
3D cell culturing and organoid drug testing
In vivo research services
End-to-end preclinical in vivo capabilities
01
In vivo imaging
Advanced in vivo imaging for longitudinal monitoring of disease progression and treatment response.
Read more →
02
Drug validation
Preclinical drug validation to assess therapeutic potential, biological activity and treatment response.
Read more →
03
Drug efficacy
In vivo drug efficacy studies to evaluate therapeutic response, dose effects and treatment outcomes.
Read more →
04
Biodistribution studies
Biodistribution studies to track drug delivery, tissue distribution and target-specific accumulation in vivo.
Read more →
05
Toxicology assessment
Preclinical toxicology studies to evaluate drug safety, tolerability and potential adverse effects.
Read more →
06
Preclinical study design
Customized preclinical study design tailored to disease models, therapeutic targets and drug development goals.
Read more →
Let us help you guide decision-making for preclinical development
Do you want to learn more about our work and how we can help you?